Seminars in Oncology

Papers
(The median citation count of Seminars in Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
TOC66
TOC49
Masthead39
PARP inhibitors for prostate cancer26
Incidence of COVID-19 in outpatients with cancer receiving active treatment in the context of a pandemic: An Andalusian cohort study21
Breast cancer care: Looking for the new normal20
Current and prospective antibody-based therapies in multiple myeloma19
A narrative review of the principal glucocorticoids employed in cancer19
Communication strategies during the COVID-19 pandemic: Unforeseen opportunities and drawbacks17
Seminars in oncology 50th anniversary15
Lung Cancer Screening and Precision Oncology13
Masthead13
The likelihood of being helped or harmed obtained from clinical trial results for cancer therapy: Can it really help?12
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review12
Successful restoration of checkpoint inhibitors efficacy after allogeneic hematopoietic cell transplant for classic Hodgkin lymphoma patients12
TOC12
Editorial Board10
Assessing Outcomes in NSCLC: Radiomic analysis, kinetic analysis and circulating tumor DNA9
Pioneering the Future of Oncology: A New Vision for Seminars in Oncology9
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease8
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects8
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis.8
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis8
Can locally developed me-too drugs aid price negotiation? An example of cancer therapies from China8
Plant polyphenols in gastric cancer: Nature's healing touch7
Battling chronic myeloid leukemia in a resource-constrained country: A case of public-private partnerships7
High tumor mutation burden mitigates the negative impact of chemotherapy history on immune checkpoint blockade therapy7
Editorial Board7
outside front cover6
outside front cover6
outside front cover6
Improving the efficacy of immunotherapy in small cell lung cancer: Leveraging recent scientific discoveries and tumor-specific antigens6
Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review6
Challenges in initiating a lung cancer screening program: Experiences from two VA medical centers5
NTRK fusion-positive cancer in nonagenarian patient. The importance of comprehensive geriatric assessment in older people for the inclusion in clinical trials5
From doctors to ancillary staff: Regional and metropolitan cancer workforce perceptions and distress resulting from COVID-19 pandemic adaptations5
Lung cancer screening at the VA: Past, present and future5
CAR T-cell therapy: A collaboration between authorized treatment centers and community oncologists5
Outside front cover5
Editorial Board5
Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab5
Masthead5
Efficacy of memantine in preventing neurocognitive dysfunction induced by radiation therapy in patients with brain metastases: A systematic review of clinical trials5
Masthead5
Editorial Board5
COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature5
Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis4
Role of neoadjuvant pembrolizumab in advanced melanoma4
Table of Contents4
Outside front cover4
Torticollis as a presenting symptom of pediatric CNS tumors: A systematic review4
Impact of CT screening in lung cancer: Scientific evidence and literature review4
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics4
The heterogeneity of Epithelioid Hemangioendothelioma (EHE): A case series and review of the literature with emphasis on treatment options4
Editorial Board3
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations3
Radiation recall dermatitis: A review of the literature3
TOC3
Editorial Board3
Which future for de-intensified treatments in HPV-related oropharyngeal carcinoma?3
Predictors of treatment refusal in patients with colorectal cancer: A systematic review3
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans3
outside front cover3
Skin metastases in the clinical and dermoscopic aspects3
Editorial Board3
Molecular biomarkers and liquid biopsies in lung cancer3
Military exposures and lung cancer in United States Veterans3
Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias3
Examining health related quality of life outcomes in multiple myeloma: Past and future perspectives3
Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy?3
Editorial Board2
Adenocarcinoma on retrorectal cystic hamartoma: An illustrative image for a very rare diagnosis2
Colorectal cancer in Ethiopia: Epidemiological trends, diagnostic and laboratory capacities, and challenges2
Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer2
Modern radiographic imaging in multiple myeloma, what is the minimum requirement?2
Editorial Board2
Scoping to analyze oncology trial participation in Australia2
Current perspectives, guiding lights to the future, and transforming care for patients with multiple myeloma2
outside front cover2
Real-world experience with CDK4-6 inhibition in the old and oldest old with a diagnosis of breast cancer2
Masthead2
Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized con2
The critical role of NLRP3 in drug resistance of cancers: Focus on the molecular mechanisms and possible therapeutics2
Importance, relevance, and pertinence of discussing mental health in the uro-oncology patient1
PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance1
Implications of reactive oxygen species on cancer formation and its treatment1
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis1
Editorial Board1
Novel targeted therapies for advanced non-small lung cancer1
Treating advanced lung cancer in older Veterans with comorbid conditions and frailty1
Defining genomic events involved in the evolutionary trajectories of myeloma and its precursor conditions1
Fingerprint change as a consequence of anticancer treatments: A systematic integrative review1
TOC1
Masthead1
The psychosocial and emotional experiences of cancer patients during the COVID-19 pandemic: A systematic review1
Cancer diagnosis in Brazil in the COVID-19 era1
Managing multiple myeloma in a resource-limited region: Diagnosis and treatment in Armenia1
Editorial Board1
0.15862798690796